CHECKPOINT THERAPEUTICS INC (CKPT) Forecast, Price Target & Analyst Ratings

NASDAQ:CKPT • US1628282063

4.26 USD
+0.03 (+0.71%)
At close: May 29, 2025
4.2705 USD
+0.01 (+0.25%)
After Hours: 5/29/2025, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHECKPOINT THERAPEUTICS INC (CKPT).

Forecast Snapshot

Consensus Price Target

Price Target
$4.42
+ 3.76% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release DateAug 11, 2025
PeriodQ2 / 2025
EPS Estimate-$0.03
Revenue Estimate7.429M
 → Full earnings forecast details

ChartMill Buy Consensus

Rating
77.78%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.42
Upside
+ 3.76%
From current price of $4.26 to mean target of $4.42, Based on 9 analyst forecasts
Low
$4.14
Median
$4.18
High
$5.04

Price Target Revisions

1 Month
0.00%
3 Months
-63.89%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for CKPT. The average price target is 4.42 USD. This implies a price increase of 3.76% is expected in the next year compared to the current price of 4.26.
The average price target has been revised downward by 63.89% in the past 3 months.
 → Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CKPT Current Analyst RatingCKPT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

CKPT Historical Analyst RatingsCKPT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
77.78%
CKPT was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CKPT.
In the previous month the buy percentage consensus was at a similar level.
CKPT was analyzed by 9 analysts. More opinions would make the average more meaningful.
 → Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-03-31D. Boral CapitalMaintains Buy -> Buy
2025-03-11HC Wainwright & Co.Downgrade Buy -> Neutral
2025-03-10D. Boral CapitalMaintains Buy -> Buy
2025-03-10Lake StreetDowngrade Buy -> Hold
2025-01-13D. Boral CapitalInitiate Buy
2024-12-16Lake StreetMaintains Buy -> Buy
2024-12-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-04HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-12HC Wainwright & Co.Maintains Buy -> Buy
2024-07-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-24HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-22HC Wainwright & Co.Reiterate Buy -> Buy
2023-12-20B. Riley SecuritiesMaintains Buy -> Buy
2023-12-19HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-16Lake StreetMaintains Buy -> Buy
2023-08-15Cantor FitzgeraldMaintains Overweight -> Overweight
2023-08-15Ladenburg ThalmannMaintains Buy -> Buy
2023-08-04HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-30Lake StreetMaintains Buy -> Buy
2023-05-17Ladenburg ThalmannMaintains Buy -> Buy
2023-05-16Cantor FitzgeraldMaintains Overweight -> Overweight
2023-04-28HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release DateAug 11, 2025
PeriodQ2 / 2025
EPS Estimate-$0.03
Revenue Estimate7.429M
Revenue Q2Q18,019.51%
EPS Q2Q83.00%
Number of Analysts3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
10.53%

Next Earnings Summary

CKPT is expected to report earnings on 8/11/2025. The consensus EPS estimate for the next earnings is -0.03 USD and the consensus revenue estimate is 7.43M USD.
 → Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CKPT revenue by date.CKPT revenue by date.
190K
-29.63%		103K
-45.79%		41K
-60.19%		41.936M
102,182.93%		189.43M
351.71%		933.21M
392.64%		391.38M
-58.06%		491.14M
25.49%		596.98M
21.55%		706.9M
18.41%		864M
22.22%
EBITDA
YoY % growth
CKPT ebitda by date.CKPT ebitda by date.
N/A
-22.19%		N/A
-62.71%		N/A
43.01%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CKPT ebit by date.CKPT ebit by date.
-58.33M
-2.84%		-52.148M
10.60%		-56.174M
-7.72%		-5.802M
89.67%		124M
2,237.28%		736.55M
493.99%		292.33M
-60.31%		388.58M
32.93%		478.26M
23.08%		606.61M
26.84%		747.56M
23.24%
Operating Margin
CKPT operating margin by date.CKPT operating margin by date.
-30,700.00%-50,629.13%-137,009.76%-13.83%65.46%78.93%74.69%79.12%80.11%85.81%86.52%
EPS
YoY % growth
CKPT eps by date.CKPT eps by date.
-7.09
4.19%		-3.33
53.03%		-1.43
57.06%		-0.18
87.52%		1.15
745.71%		6.30
446.90%		2.32
-63.27%		2.84
22.47%		3.25
14.75%		3.83
17.55%		4.65
21.60%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.03
83.00%		0.30
228.61%		0.39
156.17%
Revenue
Q2Q % growth		7.429M
18,019.51%		29.714M37.142M
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-1.433M
78.52%		16.427M
268.93%		22.37M
177.60%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CKPT Yearly Revenue VS EstimatesCKPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
CKPT Yearly EPS VS EstimatesCKPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
85.74%
EPS Next 5 Year
31.84%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
3,960.10%
Revenue Next 5 Year
711.65%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CHECKPOINT THERAPEUTICS INC / CKPT Forecast FAQ

What do analysts expect the price target to be for CHECKPOINT THERAPEUTICS INC (CKPT)?

9 analysts have analysed CKPT and the average price target is 4.42 USD. This implies a price increase of 3.76% is expected in the next year compared to the current price of 4.26.


What is the next earnings date for CKPT stock?

CHECKPOINT THERAPEUTICS INC (CKPT) will report earnings on 2025-08-11.


What are the consensus estimates for CHECKPOINT THERAPEUTICS INC (CKPT) next earnings?

The consensus EPS estimate for the next earnings of CHECKPOINT THERAPEUTICS INC (CKPT) is -0.03 USD and the consensus revenue estimate is 7.43M USD.


How many analysts cover CHECKPOINT THERAPEUTICS INC (CKPT) stock?

The number of analysts covering CHECKPOINT THERAPEUTICS INC (CKPT) is 9.